Episode 53

Non-Small Cell Lung Cancer — Targeting KRAS G12C

Featuring perspectives from Prof Solange Peters and Dr Joshua K Sabari, including the following topics:

  • Introduction (0:00)
  • Best Option for Your Patient (1:28)
  • Biological Considerations (6:26)
  • KRAS G12C Inhibitors (11:33)
  • Second-Line Treatment (13:02)
  • Current Clinical Trials in the First-Line Metastatic Setting (32:18)
  • Current Clinical Trials in the Localized Setting (49:52)
  • Current Clinical Trials with New Treatment Combinations and Agents (53:51)

CME information and select publications

All Episodes Previous Episode

About the Podcast

Show artwork for Lung Cancer Update
Lung Cancer Update
This series bridges the gap between research and patient care by providing medical oncologists and hematologists ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

Listen for free